← Evidence map

ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2015

Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis.

Hans-Peter Hartung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

46 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25344374